Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea.
Recornea has raised $530K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2025.
Recornea's investors include Scientifica Venture Capital, Health Wildcatters, ENEA Tech e Biomedical.
Recornea is headquartered in Udine, Italy.
Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea.
Recornea is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Recornea — Funding & Investors." VCBacked, July 23, 2025, https://www.vcbacked.co/company/recornea. Accessed August 14, 2026.
VCBacked. (2025). Recornea — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/recornea
{{cite web |title=Recornea — Funding & Investors |url=https://www.vcbacked.co/company/recornea |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated